QIAGEN Reports Strong Third Quarter 2008 Results
. - 31% Revenue Growth, 14% Organic Growth - 53% Adjusted Operating Income Growth - $0.21 Adjusted EPS QIAGEN N.V…
. - 31% Revenue Growth, 14% Organic Growth - 53% Adjusted Operating Income Growth - $0.21 Adjusted EPS QIAGEN N.V…
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of a new test to determine mutation…
BERTHOLD TECHNOLOGIES GmbH & Co KG and Radim SpA have entered into a partnership to realise high quality and cost effect…
Roche Applied Science and NuGEN Technologies, Inc., a leader in nucleic acid sample preparation systems, announced today…
QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) has announced today that it has entered into a worldwide exclu…
Roche NimbleGen has expanded its growing line of tools for analyzing the epigenome and genome-wide transcriptional regul…
Roche NimbleGen hat seine immer größer werdende Produktreihe zur Analyse von Mechanismen in der Epigenomik und genomweit…
NetApp erweitert sein Midrange Storage-Portfolio mit Einführung der FAS3160 und V3160 Modelle. Darüber hinaus gibt NetA…
In Zusammenarbeit mit dem Human Genome Sequencing Center des Baylor College of Medicine in Houston, Texas, hat Roche Nim…
Roche NimbleGen in cooperation with the Human Genome Sequencing Center at Baylor College of Medicine in Houston, Texas h…